4bases’paper of The Month – October 2023 -Impact of non-BRCA genes in the indication of risk-reducing surgery in hereditary breast and ovarian cancer syndrome (HBOC)
BRCA1 and BRCA2 stand out as the most well-known genes associated with hereditary breast and ovarian cancer (HBOC). Individuals carrying a pathogenic or likely pathogenic